CBD Cronos stock craters on weak Canadian weed sales and US$107M loss Cronos says its massive cash pile will help it execute its global cannabis strategy as Covid-19 pandemic derails its US CBD strategy Jared GnamAugust 7, 2020
The weed wire Innovative Industrial Properties continues earnings streak The company's share price has climbed almost 38% since its last earnings report in May Nick LabaAugust 5, 2020
COVID-19 Aphria shares tumble on $99M fourth-quarter loss But the weed giant now holds a 16.1% market share of recreational sales Jared GnamJuly 29, 2020
COVID-19 Organigram blames weak sales on delayed value product launch Moncton-based producer says Health Canada axing its Trailer Park Buds bulk product also contributed to a Q3 revenue drop Jared GnamJuly 21, 2020
COVID-19 A rough quarter for leading extractor Valens Slow of demand from clients struggling due to Covid-19 expected to hurt revenues in next quarter as well Nick LabaJuly 16, 2020
The weed wire Jushi Holdings sees rising revenues in Pennsylvania US cannabis operator reports US$8.6 million in Q1 revenues, while forecasting US$15.0 million for Q2 Jared GnamJuly 7, 2020
Cannabis Flower One books quarterly revenue spike, write-down charges Unofficial guidance for the first quarter 2020 shows continued revenue growth Nick LabaJune 16, 2020
Analysis Hexo says profits depend on more pot shop openings in Ontario, Quebec Shares of Hexo slipped another 5% after reporting a third-quarter net loss of $19.5 million Jared GnamJune 11, 2020
The weed wire Neptune Wellness forecasts big growth despite reporting big losses Revenues grew by just 4% in the last quarter, but company projects 90% growth over the current period Nick LabaJune 10, 2020
The weed wire EBITDA profitability a ‘transformational milestone’ for TerrAscend TerrAscend's strategy of focusing on US markets continue to pay off Nick LabaMay 28, 2020